HUMA KHAN: Open Payments
NPI 1750849253 · WESTBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 10 payments from 5 companies in 2025. Trend: 2023 $22 · 2024 $386 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $142 |
| Astellas Pharma US Inc | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 2 | $76 |
| Novo Nordisk Inc | 2 | $39 |
| Amgen Inc. | 1 | $16 |
Products named: UBRELVY, Veozah, CAMZYOS, Ozempic, OTEZLA, Wegovy.
Industry payments across MA — which companies pay providers there.
